Ser959
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
Home | Login
About PhosphoSiteUsing PhosphoSiteprivacy & cookiesCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Phosphorylation Site Page:
Ser959 - Kit (human)

Site Information
DHSVRINsVGSTASS   SwissProt Entrez-Gene
Predicted information:  Scansite
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 450038

In vivo Characterization
Methods used to characterize site in vivo: [32P] bio-synthetic labeling (4), mass spectrometry (1, 2, 3), mutation of modification site (4), phosphoamino acid analysis (4)
Disease tissue studied: breast cancer (2), HER2 positive breast cancer (1), luminal A breast cancer (1), luminal B breast cancer (1), breast cancer, triple negative (1, 2)
Relevant cell line - cell type - tissue: breast (1, 2), HCT116 (intestinal) (3), MDA-MB-435S (breast cell) (3), PAE (endothelial) (4)

Controlled by
Treatments: SCF (4)



References

1

Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275   Curated Info

2

Mertins P, et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13, 1690-704
24719451   Curated Info

3

Oppermann FS, et al. (2009) Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 8, 1751-64
19369195   Curated Info

4

Blume-Jensen P, Wernstedt C, Heldin CH, Rönnstrand L (1995) Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells. J Biol Chem 270, 14192-200
7539802   Curated Info

Home  |  Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2017 Cell Signaling Technology, Inc.